Adjunctive recombinant human parathyroid hormone agents for the treatment of medication-related osteonecrosis of the jaw: a report of three cases
Article in Journal of the Korean Association of Oral and Maxillofacial Surgeons (April 2024)
The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.
Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management
Article in Supportive Care in Cancer (March 2024)
The recombinant human parathyroid hormone, teriparatide as an alternative remedy for the medication-related osteonecrosis of the jaw.
Article in Orvosi Hetilap (September 2023)